Clinical Trial Update: Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection [Phase 4]

View source ↗

Summary

Phase 4 trial results assess the efficacy and safety of a fixed-dose regimen of tenofovir disoproxil fumarate + lamivudine + efavirenz in adults with HIV/HBV co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Lamivudine (lamivudine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Center for AIDS/STD Control and Prevention, China CDC | Conditions: Hiv | Phase 4 | Status: COMPLETED